Axsome Therapeutics
(NASDAQ:AXSM)
$75.68
-1.26[-1.64%]
At close: May 8
$75.68
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Mon May 6th, before the market open
The most recent conference call was at 8:00 AM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Axsome Therapeutics Stock (NASDAQ:AXSM), Quotes and News Summary

Axsome Therapeutics Stock (NASDAQ: AXSM) stock price, news, charts, stock research, profile.

Open$76.500
Close$75.680
Volume / Avg.373.512K / 737.817K
Day Range74.760 - 77.870
52 Wk Range55.020 - 98.400
Market Cap$3.594B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
56
Short Interest
19.62%
Days to Cover14.35

Recent News

Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
What's Going On Neurology-Focused Axsome Therapeutics' Stock On Monday?
Unlock insights from the SYMPHONY Phase 3 trial of AXS-12 (reboxetine) in narcolepsy patients. AXS-12 demonstrated significant reductions in cataplexy attacks, improved daytime wakefulness, and cognitive function.
Vandana Singh
Neurology-Focused Axsome Therapeutics Reports Deeper Than Expected Q4 Loss, Updates Upcoming Pipeline Milestones
Axsome Therapeutics Q4 2023 revenues surge to $71.53 million, Auvelity sales hit $130.1 million for the year. Sunosi sees 67% YoY growth.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
7
Feb
8
Mar
3
Apr
4
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AXSM
NVO

FAQ

Q

How do I buy Axsome Therapeutics (AXSM) stock?

A

You can purchase shares of Axsome Therapeutics (NASDAQ: AXSM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Axsome Therapeutics's (AXSM) competitors?

A

Other companies in Axsome Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Axsome Therapeutics (AXSM) stock?

A

The latest price target for Axsome Therapeutics (NASDAQ: AXSM) was reported by Mizuho on Wednesday, May 8, 2024. The analyst firm set a price target for 106.00 expecting AXSM to rise to within 12 months (a possible 40.06% upside). 45 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Axsome Therapeutics (AXSM)?

A

The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $75.68 last updated May 8, 2024 at 4:00 PM EDT.

Q

Does Axsome Therapeutics (AXSM) pay a dividend?

A

There are no upcoming dividends for Axsome Therapeutics.

Q

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

A

Axsome Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is Axsome Therapeutics (AXSM) going to split?

A

There is no upcoming split for Axsome Therapeutics.

Q

What sector and industry does Axsome Therapeutics (AXSM) operate in?

A

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch